ANIXA BIOSCIENCES, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $30.00 thousand for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-07-31 was $10.00K, a 11.11% increase year-over-year.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-04-30 was $10.00K, a 11.11% increase year-over-year.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-01-31 was $10.00K, a 11.11% increase year-over-year.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-10-31 was $9.00K, a 0.00% change year-over-year.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $36.00K, a 2.70% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $37.00K, a 19.57% decline from fiscal 2023.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $46.00K, a 9.52% increase from fiscal 2022.
- ANIXA BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $42.00K, a 30.00% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-07-31 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $20.00K derived: sum of 2 quarters · filed 2026-09-09 | $30.00K 10-Q · filed 2026-09-09 | $39.00K derived: sum of 4 quarters · filed 2026-09-09 | |
| 2026-04-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $20.00K 10-Q · filed 2026-06-10 | $29.00K derived: sum of 3 quarters · filed 2026-06-10 | $38.00K derived: sum of 4 quarters · filed 2026-09-09 | |
| 2026-01-31 | $10.00K 10-Q · filed 2026-03-09 | $19.00K derived: sum of 2 quarters · filed 2026-03-09 | $28.00K derived: sum of 3 quarters · filed 2026-09-09 | $37.00K derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-10-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $18.00K derived: sum of 2 quarters · filed 2026-09-09 | $27.00K derived: sum of 3 quarters · filed 2026-09-09 | $36.00K 10-K · filed 2026-01-12 | |
| 2025-07-31 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $18.00K derived: sum of 2 quarters · filed 2026-09-09 | $27.00K 10-Q · filed 2026-09-09 | $36.00K derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-04-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $18.00K 10-Q · filed 2026-06-10 | $27.00K derived: sum of 3 quarters · filed 2026-06-10 | $30.00K derived: sum of 4 quarters · filed 2026-06-10 | |
| 2025-01-31 | $9.00K 10-Q · filed 2026-03-09 | $18.00K derived: sum of 2 quarters · filed 2026-03-09 | $21.00K derived: sum of 3 quarters · filed 2026-03-09 | $33.00K derived: sum of 4 quarters · filed 2026-03-09 | |
| 2024-10-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $12.00K derived: sum of 2 quarters · filed 2026-01-12 | $24.00K derived: sum of 3 quarters · filed 2026-01-12 | $37.00K 10-K · filed 2026-01-12 | |
| 2024-07-31 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | $15.00K derived: sum of 2 quarters · filed 2025-09-10 | $28.00K 10-Q · filed 2025-09-10 | $40.00K derived: sum of 4 quarters · filed 2025-09-10 | |
| 2024-04-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | $25.00K 10-Q · filed 2025-05-28 | $37.00K derived: sum of 3 quarters · filed 2025-05-28 | $48.00K derived: sum of 4 quarters · filed 2025-05-28 | |
| 2024-01-31 | $13.00K 10-Q · filed 2025-03-11 | $25.00K derived: sum of 2 quarters · filed 2025-03-11 | $36.00K derived: sum of 3 quarters · filed 2025-03-11 | $48.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-10-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $23.00K derived: sum of 2 quarters · filed 2025-01-10 | $35.00K derived: sum of 3 quarters · filed 2025-01-10 | $46.00K 10-K · filed 2025-01-10 | |
| 2023-07-31 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | $23.00K derived: sum of 2 quarters · filed 2024-09-06 | $34.00K 10-Q · filed 2024-09-06 | $45.00K derived: sum of 4 quarters · filed 2024-09-06 | |
| 2023-04-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-06-04 | $23.00K 10-Q · filed 2024-06-04 | $34.00K derived: sum of 3 quarters · filed 2024-06-04 | $44.00K derived: sum of 4 quarters · filed 2024-06-04 | |
| 2023-01-31 | $11.00K 10-Q · filed 2024-03-12 | $22.00K derived: sum of 2 quarters · filed 2024-03-12 | $32.00K derived: sum of 3 quarters · filed 2024-03-12 | $43.00K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-10-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $21.00K derived: sum of 2 quarters · filed 2024-01-16 | $32.00K derived: sum of 3 quarters · filed 2024-01-16 | $42.00K 10-K · filed 2024-01-16 | |
| 2022-07-31 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-06 | $21.00K derived: sum of 2 quarters · filed 2023-09-06 | $31.00K 10-Q · filed 2023-09-06 | $47.00K derived: sum of 4 quarters · filed 2023-09-06 | |
| 2022-04-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-06-14 | $21.00K 10-Q · filed 2023-06-14 | $37.00K derived: sum of 3 quarters · filed 2023-06-14 | $52.00K derived: sum of 4 quarters · filed 2023-06-14 | |
| 2022-01-31 | $10.00K 10-Q · filed 2023-03-17 | $26.00K derived: sum of 2 quarters · filed 2023-03-17 | $41.00K derived: sum of 3 quarters · filed 2023-03-17 | $56.00K derived: sum of 4 quarters · filed 2023-03-17 | |
| 2021-10-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $31.00K derived: sum of 2 quarters · filed 2023-01-04 | $46.00K derived: sum of 3 quarters · filed 2023-01-04 | $60.00K 10-K · filed 2023-01-04 | $59.86K 10-K · filed 2022-01-04 |
| 2021-07-31 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-09 | $30.00K derived: sum of 2 quarters · filed 2022-09-09 | $44.00K 10-Q · filed 2022-09-09 | ||
| 2021-04-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-06-10 | $29.00K 10-Q · filed 2022-06-10 | |||
| 2021-01-31 | $14.00K 10-Q · filed 2022-03-11 | ||||
| 2020-10-31 | $51.88K 10-K · filed 2022-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |